First human tests begin for experimental drug in china
NCT ID NCT07313150
Summary
This is an early-stage study to check the safety of a new drug called QLS7305 in healthy Chinese adults. Researchers will give different doses to 60 participants and closely monitor for side effects, how the body processes the drug, and whether it affects the immune system. The study will help determine if QLS7305 is safe enough for further testing in people with medical conditions.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS - MALE AND FEMALE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.